Setipiprant NEW

Setipiprant is an orally active, selective CRTH2 antagonist. Setipiprant interacts with the hCRTH2 receptor with an IC50 of 6 nM. Setipiprant inhibits the prostanoid receptors hDP1 and hEP2 with IC50 values of 1290 and 2600 nM, respectively. Setipiprant can be used in the study of asthma and rhinitis.

Purchase process:

1. Contact the sales department to confirm the product name, quantity, price, packaging, etc.

2. After confirmation, remit the money to our company account and send detailed delivery information

3. Ship within 2 working days after payment and offer tracking number.

4. Customer confirms receipt

Rock

Whatsapp/ Signal:+8618829283179

Email: rock@horlden.com